RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+8.96%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.68B
Cap. Flow
% of AUM
-5%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
791
Reduced
2,114
Closed
100
Top Buys
| 1 |
NXP Semiconductors
NXPI
|
+$42.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$29.5M |
| 3 |
ConocoPhillips
COP
|
+$15.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$13.7M |
| 5 |
Valero Energy
VLO
|
+$9.39M |
Top Sells
| 1 |
Apple
AAPL
|
+$256M |
| 2 |
Microsoft
MSFT
|
+$175M |
| 3 |
Amazon
AMZN
|
+$112M |
| 4 |
Meta Platforms (Facebook)
META
|
+$67.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$64.4M |
Sector Composition
| 1 | Technology | 22.62% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2401
KRONOS Worldwide
KRO
$721M
| $603K | ﹤0.01% |
39,387
-400
| -1% | -$6.12K |
|
2402
Rocky Brands
RCKY
$216M
| $603K | ﹤0.01% |
11,150
-460
| -4% | -$24.9K |
|
2403
CNB Financial Corp
CCNE
$762M
| $602K | ﹤0.01% |
24,476
-740
| -3% | -$18.2K |
|
2404
Stoke Therapeutics
STOK
$1.24B
| $602K | ﹤0.01% |
15,507
-165
| -1% | -$6.41K |
|
2405
Hydrofarm Holdings
HYFM
$15.1M
| $601K | ﹤0.01% |
+997
| New | +$601K |
|
2406
Alerus Financial
ALRS
$574M
| $595K | ﹤0.01% |
19,979
-755
| -4% | -$22.5K |
|
2407
KalVista Pharmaceuticals
KALV
$775M
| $595K | ﹤0.01% |
23,177
+4,188
| +22% | +$108K |
|
2408
Akebia Therapeutics
AKBA
$777M
| $590K | ﹤0.01% |
174,241
-14,840
| -8% | -$50.3K |
|
|
TBCH
2409
Turtle Beach Corporation Common Stock
TBCH
$297M
| $589K | ﹤0.01% |
22,077
-535
| -2% | -$14.3K |
|
|
IGMS
2410
DELISTED
IGM Biosciences
IGMS
| $587K | ﹤0.01% |
7,655
-316
| -4% | -$24.2K |
|
2411
Amerant Bancorp
AMTB
$880M
| $586K | ﹤0.01% |
31,550
-1,145
| -4% | -$21.3K |
|
2412
BioXcel Therapeutics
BTAI
$51.2M
| $586K | ﹤0.01% |
848
-104
| -11% | -$71.9K |
|
|
BNFT
2413
DELISTED
Benefitfocus, Inc.
BNFT
| $586K | ﹤0.01% |
42,402
-2,290
| -5% | -$31.6K |
|
2414
Forestar Group
FOR
$1.4B
| $585K | ﹤0.01% |
25,132
-1,250
| -5% | -$29.1K |
|
2415
W&T Offshore
WTI
$261M
| $585K | ﹤0.01% |
163,087
-4,990
| -3% | -$17.9K |
|
2416
Oppenheimer Holdings
OPY
$763M
| $584K | ﹤0.01% |
14,580
-1,848
| -11% | -$74K |
|
2417
Arcutis Biotherapeutics
ARQT
$2.11B
| $582K | ﹤0.01% |
20,133
+45
| +0.2% | +$1.3K |
|
2418
VSE Corp
VSEC
$3.45B
| $579K | ﹤0.01% |
14,651
-80
| -0.5% | -$3.16K |
|
|
SCU
2419
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $578K | ﹤0.01% |
26,395
-1,345
| -5% | -$29.5K |
|
2420
Relmada Therapeutics
RLMD
$53.4M
| $577K | ﹤0.01% |
16,393
-735
| -4% | -$25.9K |
|
|
PAE
2421
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $577K | ﹤0.01% |
63,956
-3,520
| -5% | -$31.8K |
|
2422
Berry Corp
BRY
$251M
| $576K | ﹤0.01% |
104,491
-8,112
| -7% | -$44.7K |
|
2423
National CineMedia
NCMI
$423M
| $575K | ﹤0.01% |
12,449
-900
| -7% | -$41.6K |
|
2424
ARS Pharmaceuticals
SPRY
$1.04B
| $575K | ﹤0.01% |
+13,189
| New | +$575K |
|
2425
Pulmonx
LUNG
$65.6M
| $574K | ﹤0.01% |
12,555
+918
| +8% | +$42K |
|